Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
03/2003
03/13/2003CA2459077A1 Diagnosis of carcinomas
03/13/2003CA2459045A1 Antidiabetic extracts of artemisia dracunculus
03/13/2003CA2458670A1 Bv8 nucleic acids and polypeptides with mitogenic activity
03/12/2003EP1291422A2 Human nucleic acid from ovarian tumor tissue
03/12/2003EP1291016A1 New use of modafinil and the d/l enantiomer
03/12/2003EP1290193A2 Protein phosphatases
03/12/2003EP1290187A2 Humain kinases
03/12/2003EP1290180A2 Drug metabolizing enzymes
03/12/2003EP1290169A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
03/12/2003EP1290015A2 Epididymis-specific proteins with fibronectin type ii modules
03/12/2003EP1289990A1 Tetracyclic diketopierazine compounds as pdev inhibitors
03/12/2003EP1289989A2 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
03/12/2003EP1289985A2 Beta-carboline derivatives useful as inhibitors of phosphodiesterase
03/12/2003EP1289965A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP1289964A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP1289961A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
03/12/2003EP1289955A1 Piperidines for use as orexin receptor antagonists
03/12/2003EP1289561A2 Ligand conjugates and methods for preparing same
03/12/2003EP1289543A2 Formulations and methods for treating hypercoagulable states
03/12/2003EP1289534A2 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
03/12/2003EP1289526A1 Melanocortin receptor agonists
03/12/2003EP1289525A2 Tricyclic pyrazole derivatives as protein kinase inhibitors
03/12/2003EP1289519A1 Methods of treating androgen deficiency in men using selective antiestrogens
03/12/2003EP1289507A1 Use of an aldosterone antagonist for the treatment or prohpylaxis of aldosterone-mediated pathogenic effects
03/12/2003EP0979098B1 Method of treating hyperprolactinemia and prolactinomas
03/12/2003EP0964852B1 Indolecarboxylic compounds and their use as pharmaceutical compounds
03/12/2003CN1402735A Novel androgens
03/12/2003CN1402702A Beta 2-adrenergic receptor agonists
03/12/2003CN1402633A Transdermal therapeutic system with improved stability and method for production thereof
03/12/2003CN1401657A Gene sequence and use of fish testicle development factor
03/12/2003CN1401656A Gene sequence and use of fish testicle development factor
03/12/2003CN1401655A Gene sequence and use of embryogenesis regulatory factor in hypophysis of rockfish
03/12/2003CN1401383A Kidney-reinforcing Yang-invigorating pill for treating sexual impotence, and preparing process thereof
03/12/2003CN1401377A External applied medicine for treating erosion of cervix
03/12/2003CN1401373A Chinese medicine for treating male sexual disfunction and preparing process thereof
03/12/2003CN1401372A Antiinflammatory hemostatic gynecologic medicine and use thereof
03/12/2003CN1401354A Capsule for treating woman sterility
03/12/2003CN1401351A Medicine for treating menopausal syndrome
03/12/2003CN1401348A 'Taizichanning' for puerperal recovery
03/12/2003CN1401344A Chinese medicine gel for treating cervicitis and cervical erosion, and preparing method thereof
03/12/2003CN1401320A Medicine for treating menopausal syndrome
03/11/2003US6531598 Naphthostyrils
03/11/2003US6531511 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
03/11/2003US6531492 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
03/11/2003US6531478 For therapy of eating disorder, obesity, bulimia nervosa, diabetes, binge eating, anorexia nervosa, dyslipidimia, hypertension, memory loss, epileptic seizures, migraine, sleep disturbances, pain, sexual/reproductive disorders
03/11/2003US6531471 Morpholinone and morpholine derivatives and uses thereof
03/11/2003US6531468 Inhibiting serotonin reuptake in the central nervous system of a mammal
03/11/2003US6531453 Activating human NKT cell by culturing in vitro mononuclear cell fraction comprising human NKT cell in presence of specified compound or salt or solvate thereof
03/11/2003CA2102187C Use of atipamezole for the treatment of male sexual impotence
03/07/2003WO2002020481A2 Substituted 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine
03/07/2003CA2421835A1 Substituted 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridines
03/06/2003WO2003019146A2 High throughput screening assays using fatty acid synthetic enzymes
03/06/2003WO2003018820A2 Mutant recombinant adeno-associated viruses related applications
03/06/2003WO2003018758A2 Reagents and methods for smooth muscle therapies
03/06/2003WO2003018545A1 24-sulfur-substituted analogs of 1α,25-dihydroxy vitamin d¿3?
03/06/2003WO2003018049A2 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection
03/06/2003WO2003018044A1 New drug
03/06/2003WO2003018020A1 Jnk inhibitors
03/06/2003WO2003018016A1 Use of moxaverin for treating erectile dysfunction, forms of dementia or diseases associated to an arteriosclerotic occlusion
03/06/2003WO2003017991A2 Injection solution containing a dihydropyridin derivative
03/06/2003WO2003017988A1 Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groups
03/06/2003WO2003017974A1 Method of treating benign gynaecological disorders and a pharmaceutical kit for use in such method
03/06/2003WO2003017973A1 A method of treating benign gynaecological disorders and a drug delivery vehicle for use in such a method
03/06/2003WO2003017784A1 Herbal nutraceutical formulation for females/expectant mothers and its process of preparation
03/06/2003WO2003002090B1 Immunopotentiator for mammary gland of dairy cows containing lactoferrin as an active ingredient
03/06/2003WO2002034726A9 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
03/06/2003WO2002022132A8 Novel topical oestroprogestational compositions with systemic effect
03/06/2003WO2001077146A3 Compounds and methods for modulating endothelial cell adhesion
03/06/2003US20030045829 Therapeutic agent delivery tampon
03/06/2003US20030045702 Secreted Chlamydia polypeptides and method for identifying such polypeptides by their secretion by a type III secretion pathway of a gram-negative bacteria
03/06/2003US20030045583 Novel succinate salt of O-desmethyl-venlafaxine
03/06/2003US20030045554 Such as 1-(2-thien-2'-yl- 2-oxoethyl)-3-((3-phenylmethyl) pyrazol-5-yl)pyridinium bromide for treating diseases caused by the accumulation of AGE (Advanced Glycation Endproducts); antidiabetic/ antiaging agents
03/06/2003US20030045525 Particularly in the treatment of benign prostatic hyperplasia.
03/06/2003US20030045466 Calcium binding protein
03/06/2003US20030044898 Nucleotide sequences coding polypeptide for use in the treatment of asthma, parkinson's, heart defects, hypotension, urogenital and bone disorders
03/06/2003US20030044892 Novel human G-protein coupled receptor, HGPRBMY6, expressed highly in small intestine
03/06/2003CA2458574A1 Reagents and methods for smooth muscle therapies
03/06/2003CA2458565A1 New angiogenesis inhibitors based on soluble cd44 receptor hyaluronic acid binding domain
03/06/2003CA2458131A1 Jnk activation inhibitor
03/05/2003EP1288299A2 TRNA synthetase
03/05/2003EP1288227A1 Coactivator of nuclear receptors
03/05/2003EP1288206A1 Substituted benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors
03/05/2003EP1287817A1 Method of treating uterine leiomyomas and intravaginal drug delivery vehicle for use in such method
03/05/2003EP1287035A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
03/05/2003EP1287034A2 Derivatives of breast cancer antigen her-2 for therapeutical use
03/05/2003EP1287017A1 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity
03/05/2003EP1286997A1 6-phenylpyrrolopyrimidinedione derivatives
03/05/2003EP1286992A1 Piperidyindoles as serotonin receptor ligands
03/05/2003EP1286973A2 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists
03/05/2003EP1286962A1 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds
03/05/2003EP1286693A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
03/05/2003EP1286666A2 Starter kit for low dose oral contraceptives
03/05/2003EP1286659A2 Macromolecular drug complexes and compositions containing the same
03/05/2003EP1169316B1 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
03/05/2003EP1109549B1 Analgesic use of podophyllotoxin for treating pain conditions in female genital organs
03/05/2003EP0892791B1 N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS
03/05/2003EP0667784B1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring
03/05/2003CN1400975A 嘌呤衍生物 Purine derivatives
03/05/2003CN1400970A Substituted arylpyrazines
03/05/2003CN1400968A Method for preparing alpha sulfonyl hydroxamic acid derivatives
1 ... 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 ... 557